I

Inozyme Pharma

63 employees

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$70M

from 9 investors over 9 rounds

I

Inozyme Pharma raised $60M on July 27, 2023

Investors: Wedbush Securities

I

Inozyme Pharma raised $70M on July 26, 2022

Investors: K2 HealthVentures

I

Inozyme Pharma raised $67M on April 10, 2019

Investors: Sanofi Ventures, RA Capital Management, L.P., Longitude Capital, Sofinnova Ventures, Russia technology fund and Novo Holdings

I

Inozyme Pharma raised $49M on November 15, 2017

Investors: Sanofi Ventures and Longitude Capital

FAQ